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Introduction: Morgellons disease (MD) is a contested dermopathy that is associated with
Borrelia spirochetal infection. A simple classification system was previously established to
help validate the disease based on clinical features (classes I-IV).
Methods: Drawing on historical and pathological parallels with syphilis, we formulated
a more detailed staging system based on clinical features as well as severity of skin lesions
and corresponding histopathological infection patterns, as determined by anti-Borrelia
immunohistochemical staining.
Results: Clinical classes I-IVof MD are further categorized as mild, moderate and severe, or
stages A, B and C, respectively, based on histopathological findings. Stage A lesions demon-
strated little or no immune infiltrates and little or no disorganization of cells; macrophages were
not present, and hemorrhage was negligible. Extracellular isolated spirochetes and intracellular
staining of keratinocytes in the lower epidermis was occasionally seen. Stage C lesions demon-
strated positive staining of keratinocytes in the stratum basale and stratum spinosum and positive
intracellular staining of macrophages for Borrelia. Aggregate Borrelia colonies were frequently
encountered, hemorrhage was frequent, and intracellularly stained fibroblasts were occasionally
seen. Stage B lesions demonstrated a pattern intermediate between Stages A and C.
Conclusion: The enhanced staging system provides objective criteria to assess the severity
of dermopathy in MD. Further studies are needed to determine the optimal treatment for MD
based on this staging system related to Borrelia infection.
Keywords: Morgellons disease, Lyme disease, Borrelia burgdorferi, relapsing fever
Borrelia, tick-borne disease, syphilis, Treponema pallidum
Introduction
Morgellons disease (MD) is a dermatological condition in which lesions that
contain unusual filamentous inclusions and/or projections spontaneously arise.1–5
The filaments are distinctive in part due to their varied white, red, blue, green or
black coloration, and because visually they resemble microscopic textile fibers.6–9
In addition, the dermopathy may be accompanied by formication (sensation of
something crawling on skin). Coupled with the mistaken belief that the fibers are
derived from textiles, healthcare professionals frequently and erroneously diagnose
the condition as a form of delusional infestation (DI) or the legacy terms delusional
parasitosis (DP) and delusions of parasitosis (DOP).6,7,10
In addition to filamentous dermopathy, patients frequently experience Lyme-like
symptoms such as musculoskeletal, neurological and cardiovascular manifestations
suggestive of spirochetal etiology.1–5,8 Cohort studies indicate that most patients
with MD test positively for Borrelia infection and/or have a clinical Lyme disease
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(LD) diagnosis.4,11–13 Two separate cohort studies have
demonstrated that MD afflicts approximately 6% of LD
patients.11,14 Thus it has been suggested that MD is
a physiological response to spirochetal infection in geneti-
cally predisposed patients, and there is an abundance of
experimental data to support the hypothesis.8,9
Borrelia infection is caused by members of the Borrelia
genus encompassing the LD group, also known as Borrelia
burgdorferi (Bb) sensu lato (Bbsl), and the Relapsing Fever
Borrelia (RFB) complex, the causative agents of LD and
relapsing fever (RF), respectively. Bbsl and RFB have been
repeatedly and consistently detected in tissue and fluid speci-
mens taken from MD subjects.8,9,12,13,15 Furthermore, using
sensitive molecular methodologies, Bb and RFB have been
directly detected and cultured from skin lesions demonstrating
MD pathology,8,9,12,13,15–18 thus satisfying many of the criteria
outlined in Fredricks and Relman’s molecular guidelines for
establishing disease causation.19 Borrelia spirochetes have
been detected in MD tissue and body fluid specimens, both
directly in dermatological specimens and in cultures from 25
North American MD patients using a combination of micro-
scopic, histopathological and molecular methods. Most of the
Borrelia species detected were genetically identified as Bb
sensu stricto (Bbss), but B. garinii and B. miyamotoi were
also confirmed.12
In a separate study, 90% of a cohort of 30 MD patients
tested positively for exposure to and/or infection with Borrelia
spirochetes using serological and molecular techniques. Of
these, 53% of the cohort tested positive for Bb, RFB or both
using PCR amplification and confirmatory sequencing.13 To
date, to the best of our knowledge, five independent labora-
tories have confirmed the presence of Borrelia DNA in MD
skin specimens using PCR technology and confirmatory DNA
sequencing, and seven independent laboratories have detected
Borrelia DNA by direct testing or in cultures of blood, genital
secretions and skin specimens taken fromMD patients.8,9,13,20
If sensitive and specific detection methods are used, the detec-
tion of Borrelia spirochetes directly in MD patient specimens
is consistent and reproducible, thus providing evidence sug-
gestive of causality.
In addition to members of the genus Borrelia, other
members of the Spirochaetaceae family might be able to
induce MD. Various members of the genus Treponema
cause a comparable condition, bovine digital dermatitis, in
cattle.5 T. denticola has been detected in some MD skin
specimens, although not independently of Bbsl.5 Because
Treponema is known to cause a comparable condition in an
animal model, and because treponemes are spirochetes like
Borrelia spp., it is possible that T. denticola or other patho-
genic treponemes could be key etiologic factors in the evolu-
tion of MD in some patients. In support of that hypothesis,
there is historical evidence linking MD-like cases to trepo-
nemal infection, as discussed below.
DI is defined as the fixed, false belief of being infested with
parasites or other infectious agents. In 1938, the Swedish physi-
cianEkbompublished a series of case studies describing patients
with formication coupled with the false belief of insect
infestation,21 and consequently cases of DI are often referred to
as “Ekbom’s syndrome”.6,7 Ekbom reported that patients in his
study presented collections of hairs, skin and sand-like particles
that are comparable to what we see in MD self-collected
specimens.21 MD is frequently associated with formication,
and some MD patients mistakenly believe that they have
a parasitic infection or infestation. Consequently, MD has been
misrepresented as a form of Ekbom’s syndrome.8,9 Interestingly,
three out of seven of Ekbom’s subjects had syphilis, and three
years before Ekbom’s studies were published, the French physi-
cianVié reported that 6/8 of hisDI cohort had documented cases
of syphilis.21,22 Although we have not detected T. pallidum in
any MD subjects to date, given that there is a historical associa-
tion with T. pallidum infection in comparable cases, it is reason-
able to hypothesize that T. pallidum could be an etiologic factor
in a subset of MD patients.
Although spirochetal infection appears to be the key
etiologic factor in MD evolution, MD patients have a high
incidence of other co-infecting tickborne diseases, with
Babesia infection being most frequently reported.4,11 Other
pathogens have been detected directly in MD dermatological
specimens, although less frequently and less consistently
than Borrelia spp. These pathogens include the co-
infecting tickborne pathogens Bartonella henselae and
Rickettsia spp., and the common human pathogens
Helicobacter pylori (Hp) and T. denticola.8,13,15,23–25
Mixed Bb and Hp aggregate structures consistent with bio-
films that contain alginate and amyloid protein structures
have been identified in MD skin specimens.15 Confocal
microscopy of mixed aggregates revealed that Bb occupied
the central portion of aggregates while Hp occupied the
periphery, suggesting that they could have different func-
tional roles, but also suggesting that Bb infection was estab-
lished first followed by Hp infection.15 In either case, the
results suggest that mixed Borrelia biofilms may play a role
in MD development and contribute towards Borrelia persis-
tence and disease chronicity. Although the role of other
pathogens and mixed infections in MD skin remains to be
determined, it is possible that other microorganisms play
Middelveen et al Dovepress
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a part in MD development and could be co-involved etiolo-
gical factors in individual patients.
Histochemical studies demonstrate that the cutaneous
filaments in MD are not self-implanted synthetic man-made
textile fibers, but are hair-like human biofilaments composed
of the structural proteins keratin and collagen, the products of
keratinocytes and fibroblasts, respectively.5,8,9,17,26 The cel-
lular base of attachment at the stratum basale is nucleated and
continuous with surrounding skin cells, consistent with
human cellular origin.5,8,9,17,26 Furthermore, the characteris-
tic blue color seen in some fibers results from melanin
pigmentation, and blue filaments contain melanocytes and
melanin granulation, providing irrefutable evidence that
these are not synthetic manufactured fibers.5,8,9,17 Thus, the
skin fibers seen inMDpatients are biofilaments that appear to
be aberrantly produced in response to spirochetal infection.
The classification of diseases provides a foundation for
identifying causation of morbidity and mortality, thus
allowing actions to be taken to save lives and lessen
suffering.27 Classification of diseases is epidemiologically
fundamental as it provides a common language, allowing
data regarding health-related concerns to be compiled and
shared between medical professionals.27 The following
clinical classification system for MD, based on duration
and location of MD lesions, was previously proposed:8,9,12
1. Early localized: lesions/fibers present for less than
three (3) months and localized to one area of the
body (head, trunk, extremities).
2. Early disseminated: lesions/fibers present for less
than three (3) months and involving more than one
area of the body (head, trunk, extremities).
3. Late localized: lesions/fibers present for more than
six (6) months and localized to one area of the body
(head, trunk, extremities).
4. Late disseminated: lesions/fibers present for more
than six (6) months and involving more than one
area of the body (head, trunk, extremities).
The purpose of the above classification scheme was to provide
a clinical framework to validate and standardize the diagnosis
of MD. The present study applies the above classification
scheme in conjunction with an additional staging system
based on the severity of lesions along with corresponding
histological evidence of infection. Disease staging is
a classification system using objective medical criteria to
evaluate disease severity and assess disease progression.28
Because Borrelia spp. are the key pathogens encountered in
MD tissue, we focused our staging system on the infection
patterns revealed by anti-Borrelia immunohistochemical
(IHC) staining. Together, classification and staging provide
corroborative data to validate this neglected dermopathy. In
addition, staging will provide a framework to help healthcare
professionals assess disease evolution and customize treat-
ments based on the stage of infection.
Materials and Methods
Cohort Selection
Patients from across North America were selected for
study, providing they met the case definition for MD as
determined by a health care practitioner, and that they had
lesions suitable for histological sectioning. The case defi-
nition used in this study required the presence of sponta-
neously-developing cutaneous lesions with embedded or
projecting red, white, blue, green or black filaments. Prior
testing for Borrelia infection was not required. The MD
patients were then classified for duration and location of
MD lesions, as previously proposed.8,9,12
The study was performed in accordance with the
Declaration of Helsinki. Written informed consent for partici-
pation was obtained from all subjects, both MD patients and
control subjects, in accordance with the specimen collection
protocol approved by the Western Institutional Review Board
(WIRB), Puyallup, WA. Consent to publish results was
obtained from all subjects. The University of New Haven
IRB Committee also approved the study as exempt under 45
CFR 46.101(b)(4). The identification, health status and demo-
graphic information of study subjects were not provided to
research laboratories. All human samples were submitted to
participating laboratories and processed in a blinded manner.
Histology
Dermatological specimens were submitted to McClain
Laboratories LLC, Smithtown, NY. Skin specimens were
taken from lesions showing MD pathology. The MD skin
specimens collected for histological study mainly con-
sisted of thickened callus material removed from lesions
exhibiting embedded or projecting filaments. Normal com-
mercially available human skin (BioChain Institute,
Newark, CA) was included as a negative control. The
MD skin specimens along with normal healthy skin were
sent for histological processing in a blinded manner.
For further comparison, additional controls were as fol-
lows: Liver from a mouse experimentally infected with Bb,
used for positive comparison as previously described.12,29
Dovepress Middelveen et al
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Negative controls included: a culture pellet of mixed Gram-
positive bacteria (Staphylococcus spp. and Micrococcus spp.)
combined with gelatin; a culture pellet of mixed Gram-
negative bacteria (Escherichia coli and Klebsiella spp.) com-
binedwith gelatin; a biopsy from a psoriasis case; and a biopsy
from skin with fungal infection. All specimens including
experimental specimens and controls were formalin-fixed,
blocked and sectioned, then IHC-stained to detect Borrelia
using an unconjugated rabbit anti-Bb polyclonal antibody,30
incubated with an alkaline phosphatase probe (Biocare
Medical #UP536L) followed by a chromogen substrate
(Biocare Medical #FR805CHC), and counterstained with
hematoxylin. Titration was conducted to define optimal anti-
body dilutions. Borrelia fluorescent in situ hybridization
(FISH) was performed as previously described.12,29 Samples
were visualized using a Nikon Eclipse E200 microscope, and
images were taken with a Nikon DS-L3 camera.
Serology: IGeneX Laboratory
Western blot (WB) assays were performed as described
previously to detect IgM and IgG antibodies reactive to Bb
and RFB.13,31,32
PCR: University of New Haven
All skin specimens including skin from MD specimens and
normal skin from healthy controls were submitted for PCR
testing in a blindedmanner. All PCR assays were performed in
triplicate.BorreliaDNAwas extracted as previously described,
and Borrelia gene targets were detected by either real-time
PCR using a published TaqMan assay targeted to a 139-bp
fragment of the Borrelia 16S rRNA gene, or by nested PCR
targeting the following genes: 16S rRNA, flagellin (Fla),
OspC, uvrA and pyrG genes.12,20,29,33–35 PCR amplification
was confirmed by Sanger sequencing and compared by
BLAST analysis using the GenBank database (National
Center for Biotechnology Information), as described
previously.12,20,29
PCR: Australian Biologics
DNA was extracted from culture pellets using the DNeasy
Blood and Tissue® kit (Qiagen) as previously
described.12,14,16,20,36 Specimens were tested for the presence
of Borrelia DNA and Treponema denticola/Treponema pal-
lidum DNA targets. Blinded samples were run in duplicate
with positive and negative controls using real-time PCR
targeting the Borrelia 16S rRNA and endpoint PCR targeting
the rpoC gene, as previously described.12,14,16,20,36 Sanger
sequencing followed by BLAST analysis was used for gene
analysis, as described previously.12,14,16,20,36
PCR: IGeneX
Multiplex PCR was performed for the detection of Bb and
RFB in clinical samples as described previously.13 Sanger
sequencing was performed on all positive Bb and RFB
amplicons, confirming Borrelia derivation.
Results
Cohort
Sixteen subjects were selected whomet the case description for
MD as determined by a healthcare professional and who had
suitable dermatological specimens for study. PCR and serolo-
gical evidence of exposure to or infection with Borrelia and
other co-involved pathogens is summarized in Table 1. All
patients in our study had evidence of infection and/or exposure
to Borrelia. Eight patients had serologic evidence of infection
and/or exposure to Bb, and two patients had serologic evidence
of infection and/or exposure to RFB. Twelve patients had
detectable Bbsl DNA and six patients had detectable RFB
DNA in clinical specimens. Nine patients had evidence of
infection and/or exposure to co-involved pathogens as follows:
Hp (9), Bartonella henselae (5), Babesia spp. (2), T. denticola
(2), Ehrlichia chaffeensis (1), Anaplasma phagocytophilum (1),
Chlamydia pneumonia (1), Toxoplasma spp. (1), and
Mycoplasma spp. (1). Of the subjects in our study, 14/16 were
tested by PCR technology for the presence of T. denticola and
T. pallidum DNA. All were negative for T. pallidum, and 2/14
were positive for T. denticola DNA, but T. denticola was not
found independently of Borrelia DNA.
Histology
The degree of severity of the clinical presentation corre-
sponded with the degree of severity of the histological
patterns. A few sections had visible positively stained
individual spirochetes and/or cysts (Figure 1). However,
most Borrelia infection was associated with basal kerati-
nocytes or was present in aggregate colonies, and to
a lesser extent among keratinocytes in the stratum spino-
sum. In general, all lesions, regardless of the degree of
severity, had visible intracellular and intercellular Bb
infection of keratinocytes (Figure 2A and B). As the
degree of severity progressed, the degree of cell disar-
rangement, hemorrhage, presence of macrophages stained
with anti-Bb immunostains, presence of fibrin, vacuoles or
necrosis, and presence of Borrelia aggregate colonies
Middelveen et al Dovepress
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Table 1 Summary of Patient Data
Patient Serological Evidence
of Bb/RFB
Molecular Evidence of Bb/
RFB
Serological Evidence of Co-
Infections
Molecular Evidence of Co-
Infections
M-1) + Bb IGX
IND RFB IGX
PCR:
+ RFB skin IGX (S)
+ Bb spp. skin UNH (S)
+ Bb skin AB
+ B. microti IGX
+ B. henselae IGX
PCR:
+ B. henselae skin IGX
+ Hp skin UNH
M-2) Negative PCR:
+ Bb serum IGX
+ Bb skin UNH (S)
+ Bb skin AB
+ E. chaffeensis,
+ A. phagocytophilum IGX
PCR:
+ Hp skin UNH
+ B. henselae skin IGX
FISH:
+ B. henselae IGX
M-3) + Bb IGX PCR:
+ Bb skin UNH (S)
+ Bb blood culture UNH
+ Bb skin AB
Not tested Not tested
M-4) + Bb IGX PCR:
+ RFB PCR IGX (S)
+ Bb skin UNH
Negative PCR:
+ Hp skin UNH
+ B. henselae skin IGX
M-8) Negative PCR:
+ Bb skin (S) UNH
+ Bb blood culture UNH
Not tested Not tested
M-10) + Bb IGX
+ RFB IGX
PCR:
+ Bb skin (S) UNH
+ Bb skin AB
+ Bb GI specimen AB
+ RFB serum (S) IGX
+ Hp
+ Mycoplasma spp.
+ Toxoplasma gondii
+ Chlamydia pneumoniae
Lab unknown
PCR:
+ Hp UNH
+ T. denticola skin AB
M-11) Not tested PCR:
IND Bb skin UNH
+ RFB skin (S) IGX
Not tested PCR:
+ B. henselae IGX
PCR:
+Hp skin UNH
FISH:
+ B. henselae IGX
M-12) + Bb IGX FISH: + Bbsl spp Negative Not tested
M-13) + Bb IGX PCR:
+ Bb skin UNH
+ Bb blood culture UNH
+ Bb blood culture AB
+ Babesia spp. IGX
PCR:
+ Hp skin UNH
M-15) Not tested PCR:
+ Bb skin AB
Not tested Not tested
M-16) Not tested PCR:
+ Bb skin (S) AB
Not tested PCR:
+ Hp skin UNH
M-18) Not tested PCR:
+ Bb skin (S) IGX
+ Bb skin (S) UNH
+ B. henselae Dynacare, Canada
PCR:
+ Hp skin UNH
+T. denticola skin AB
(Continued)
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became increasingly apparent (Figure 2–6). The histologi-
cal observations and classifications of individual subjects
and corresponding data are summarized in Tables 2 and 3.
Localized lesions tended to be less severe (Stages A or B),
while disseminated lesions tended to be more severe
(Stages B or C). Disseminated lesions that were less severe
were associated with partial treatment with antibiotics.
Staging sorted by classification is summarized in Table 4.
The results of histological controls were as follows:
anti-Bb immunostaining showed positive reactivity in the
experimentally Bb-infected mouse liver positive controls,
and failed to show reactivity in all negative controls,
including mixed Gram-positive bacteria, mixed Gram-
negative bacteria, sections of normal human skin, biopsy
sections of human skin with fungal infection, and biopsy
sections of human skin with psoriasis.
Discussion
Case Definitions of MD
Various working case definitions have been previously
proposed for MD, including the following:
A somatic LD-like illness associated with spontaneously
appearing, slowly healing, filamentous, ulcerative skin lesions,
with the key diagnostic criterion being colored, white, or black
filaments protruding from or embedded in skin.8,9
Case definitions are important in medicine because they
provide criteria used to determine whether an individual
has a disease, condition or health event of interest.37 In
recognition that the development of MD may involve
mixed infection, we would like to refine and further
develop the working case definition for MD as follows:
Morgellons disease is a dermatological condition character-
ized by multicolored filaments embedded within or projecting
from skin. It is predominantly associated with spirochetal
infection caused by members of the genus Borrelia, as well
as infection with other tick-borne and non-tick-borne patho-
gens including Helicobacter pylori and Treponema denticola.
Infection Associated with MD
Our objective in this study was to correlate histological
observations with lesion severity in order to create
Table 1 (Continued).
Patient Serological Evidence
of Bb/RFB
Molecular Evidence of Bb/
RFB
Serological Evidence of Co-
Infections
Molecular Evidence of Co-
Infections
M-19)
CDC + Bb 2-tiered, Mayo
Clinic
FISH: + Bbsl spp. Not tested PCR:
+ Hp skin UNH
M-23)
+ RFB IGX
Negative Not tested Not tested
M-25)
+ Bb Spectracell
laboratories
PCR:
IND Bb skin AB
+ RFB blood/serum IGX
Not tested Not tested
M-29) Not tested PCR:
+ Bb skin UNH
+ Bb skin AB
Not tested Not tested
Abbreviations: S, sequenced; IND, indeterminate; RFB, Relapsing Fever Borrelia; Bb, Borrelia burgdorferi; Hp, Helicobacter pylori; UNH, University of New Haven; AB,
Australian Biologics; IGX, IGeneX; PCR, polymerase chain reaction; FISH, fluorescent in situ hybridization.
Figure 1 Individual spirochete among keratinocytes, stratum basale, detected with
anti-Bb immunostain. 1000× magnification.
Middelveen et al Dovepress
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a staging system to track the evolution of MD lesions. We
relied on IHC and/or PCR to identify Borrelia infection.
Using anti-Bb IHC, we observed distinctive patterns of
spirochetal infection that correlated with the severity of
the lesions (Figure 1–7). Positive staining occurred in
association with keratinocytes of the lower epidermis for
all levels of severity. Mild lesions demonstrated little or no
immune infiltrates and little or no disorganization of cells;
macrophages were not present, and hemorrhage was neg-
ligible. Anti-Bb IHC revealed occasional extracellular
individual isolated spirochete and cystic forms as well as
intracellular staining of keratinocytes in the lower epider-
mis. Severe lesions demonstrated positive staining of ker-
atinocytes in the stratum basale and stratum spinosum and
positive intracellular staining of macrophages. Aggregate
Borrelia colonies were frequently encountered, hemor-
rhage was frequent, and intracellularly stained fibroblasts
were occasionally encountered. Moderate lesions demon-
strated a pattern that was intermediate between mild and
severe lesions (Table 1–4). The specific patterns of spir-
ochetal infection that we observed provide strong evidence
that MD is not psychogenic in origin but is the result of an
infectious process. The proposed histological staging sys-
tem is outlined in Table 5.
Recent studies linking Borrelia infection and MD provide
evidence meeting many of the criteria proposed by Fredricks
and Relman’s molecular guidelines for establishing disease
causation with sequence-based technology.12,13,15,19 There
Figure 2 (A) Staging based on keratinocyte histology. 200× magnification. Upper left: Control skin and hair follicle stained with anti-Bb immunostain. Upper right: Stage A, Limited
intracellular staining of basal keratinocytes, detected with anti-Bb immunostain. Lower left: Stage B, More extensive intracellular staining of basal keratinocytes with fiber, detected with
anti-Bb immunostain. Lower right: Stage C: Intracellular staining of basal keratinocytes with macrophages and clumps of cells, detected with anti-Bb immunostain. (B) Stage C: Higher
power view of intracellular staining of basal keratinocytes in disarranged cell layers, detected with anti-Bb immunostain. 1000× magnification.
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are approximately 52 recorded species of Borrelia, of which
21 are classified into the LD group and 29 are classified into
the RFB group (two species remain unclassified). Both Bb and
RFB have been consistently detected in MD
specimens.12,13,15,17,18 Although other pathogens have been
detected in MD dermatological specimens, Borrelia spiro-
chetes are the pathogens most consistently detected in MD
lesions. Therefore, our proposed staging system focuses on the
infectious patterns of Borrelia spp. as seen at the cellular level
in histological sections from MD lesions.
Comparison Between MD and Syphilis
Classification and staging of disease processes are human
concepts that enable us to categorize diseases, but conve-
nient grouping is not found in nature. Comparison between
historical accounts of syphilis and syphilis cases that are
seen today in immunocompetent subjects demonstrates
Figure 3 Intracellular staining of macrophages detected with anti-Bb immunostain.
1000× magnification.
Figure 4 Vacuoles in epidermis reactive with anti-Bb immunostain. 1000×
magnification.
Figure 5 Borrelia aggregate colonies in MD skin samples. (A) Borrelia aggregate
colonies showing spirochetes with helical morphology detected with anti-Bb immu-
nostain. 1000× magnification. (B) Mixed Bb aggregate colonies showing positively
staining Borrelia detected with anti-Bb immunostain and negatively staining bacteria.
400× magnification.
Figure 6 Aggregate Bb colonies detected with anti-Bb immunostain interspersed
with unusual brown and blue melanin deposits. 1000× magnification.
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Table 2 Summary of Clinical Classification, Histological Pattern and Severity, and Subsequent Stage Assignment
Patient Clinical
Classification
Lesions Characteristics and
Severity
Histological Pattern and Severity Histological
Stage
M-1) III - Late
localized
Pinpoint vesicles, small calluses on
fingers. Hyaline filaments.
Mild. Epithelium not disorganized, Bb staining primarily in keratinocytes of
stratum basale. Intracellular Bb staining of superficial vacuolated cells. No
hemorrhage, little to no infiltrate, Some staining present on a filament section.
A
M-2) IV - Late
disseminated
Corporeal lesions, began primarily
on jawline and scalp, clearing then
breaking out on first on legs, arms,
followed by the back and buttocks,
jagged ulcerations, crusty calluses.
Red, blue and hyaline filaments,
embedded in calluses and projecting
from exposed dermis where calluses
have peeled off.
Severe. Many Borrelia aggregate colonies (some large) scattered through the stratum
basale and stratum spinosum. Intracellular staining of keratinocytes, some are
vacuolated and necrotic. Individual helical spirochetes are visible in the aggregate
structures. Basal layer is disarranged and not distinctive and epithelium is disorganized.
Limited inflammatory infiltrate, composed primarily of macrophages indicating
chronicity, with Bb intracellular immunostaining. Some macrophages demonstrate
necrosis/vacuolization. Some fibrin deposition in the dermis. Strongly positive Bb
staining of larger filaments, originating in the basal layer. Positively Bb stained fiber
sections. Hemorrhage present. Blue and black melanin granules present.
C
M-3) I - Early
localized
Isolated thick calluses on outer
thigh following injury to area.
Embedded blue filaments
throughout calluses.
Moderate. Staining is primarily located in basal cell layer. Positive intercellular and
intracellular immunostaining of basal keratinocytes. Some Bb immunostaining of spindle-
shapedfibroblasts in dermis. SomeBb intracellular staining ofmacrophages, both in dermis
and occasionally in epidermis. Small amount of hemorrhage. Strongly Bb positive staining
around thick fibers (~10 μm in diameter) with origin in basal cell layer, growing down
towards dermis. Some isolated Bb positively Bb staining cysts.
B
M-4) IV - Late
disseminated
Irritation and itching of skin,
primarily on abdomen, and face,
lichenoid with some scaling and
sloughing of skin. Visible hyaline
filaments protruding from skin.
Mild. Bb staining of keratinocytes in stratum basale, some in stratum spinosum. No
hemorrhage, no infiltrate. Some gelatinous secretion at the site of an abrasion, is
strongly positive Bb immunostained with visible spirochetes. Strongly Bb stained basal
layer, predominantly intracellular Bb staining of keratinocytes, some vacuolated,
showing necrosis. Somemacrophages present that are intracellularly Bb stained. Larger
fiber section within the basal layer is surrounded by Bb staining.
A-B
M-8) IV - Late
disseminated
Scattered papules calluses. Visible
hyaline filaments embedded in
calluses.
Moderate. Basal layer is strongly Bb stained and is severely disarranged and
disrupted, with intracellular Bb staining of keratinocytes as well as many
vacuolated necrotic keratinocytes. No hemorrhage. Little infiltrate, mostly
macrophages in upper dermis, with intracellular Bb staining in macrophages,
some macrophages are vacuolated and necrotic. Borrelia aggregates not present.
Intracellular Bb staining of keratinocytes. Strongly Bb stained larger fibers
(~10–20 μm in diameter) of basal cell origin, growing towards the dermis.
B
M-10) IV - Late
disseminated
Vesicular lesions, and thickened
calluses corporeal. Embedded blue
filaments in calluses.
Moderate. Vacuolated, necrotic positive Bb stained keratinocytes and fibrin
present in basal layer. Vacuoles are associated with strongly Bb positive staining.
Many Borrelia aggregate colonies and individual spirochetes are present among
basal keratinocytes. Some hemorrhage, mostly positive Bb intracellular staining
of macrophages. Strongly-positive Bb staining is present at the base of large
filament (5–10 μm in diameter) that originates from stratum basale. Many small,
unstained blue fiber sections (approx. 1 μm in diameter) embedded along the
basal keratinocytes. Some unusual melanin granules and deposits, some with the
same blueish hue are scattered among blue fiber sections and keratinocytes.
B
M-11) IV - Late
disseminated
Corporeal lesions, jagged
ulcerations, crusty calluses.
Hyaline filaments in calluses.
Severe. Bb staining is predominantly in the basal cell layer, demonstrating intracellular
staining of keratinocytes. Somenecrosis among positively-stained keratinocytes. In dermis,
there is not a lot of inflammatory infiltrate, but there aremacrophages that are positively-
stained intracellularly. Macrophages show various stages of invasion, and some are
vacuolated and necrotic. Some positive intracellular Bb staining of spindle-shaped
fibroblasts. Basal layer is are disarranged. Strongly positive Bb staining of larger filaments
(5–10 μm in diameter) that originate from stratum basale and are nucleated at base of
origin. Smaller, unstained micro fibers (approx. 1 μm in diameter) are scattered in the
stratumspinosumand appear to haveoriginated from the cup-shapedbaseof a larger fiber
with origin in the stratum basale. Hemorrhage visible.
C
(Continued)
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Table 2 (Continued).
Patient Clinical
Classification
Lesions Characteristics and
Severity
Histological Pattern and Severity Histological
Stage
M-12) I - Early
localized
Minor inflammation, itching and
folliculitis, primarily dorsal aspect
of arms, some calluses and
ulcerations. Filaments visible in
calluses.
Mild. Bb Staining primarily intracellular within keratinocytes of stratum basale
and stratum spinosum. Small Borrelia aggregates and fibrin in stratum spinosum.
No hemorrhage, little to no infiltrate, epithelium not disorganized.
A
M-13) IV - Late
disseminated
Deep, erosive ulcerations primarily
on face, with secondary
Staphylococcus aureus infection.
Mucosal ulcerations. Hyaline
filaments present in dermatological
specimens. Gastrointestinal
ulcerations and adhesions reported
requiring hospitalization.
Moderate. Bb staining is concentrated in the basal layer, with intracellular staining
of keratinocytes. Borrelia aggregate colonies are within the dermis. Basal layer is
necrotic and vacuolated. Strongly positive Bb staining is present on filaments,
particularly at the base of attachment to basal layer. Keratinocytes are visible in
the base of the fiber and demonstrate intracellular Bb staining.
B–C
M-15) III - Late
localized
Inflammation and small vesicles
and papules on arms and torso.
Mild. Positive Bb staining present in the stratum basale, with intracellular Bb
staining of basal keratinocytes. Small to medium positively stained aggregates are
present among necrotic keratinocytes. Individual positive Bb stained extracellular
spirochetes are present adjacent to the basal layer. Individual positive Bb stained
helical spirochetes are visible in aggregates. Small amount of hemorrhage
present. Melanin deposits visible alongside strongly Bb stained aggregates.
A–B
M-16) I - Early
localized
Thickened calluses primarily on
legs
Mild. Weakly positive Bb stained keratinocytes in the stratum basale, as well as
some fibrin deposition. Basal cells are slightly disarranged. Positive Bb staining is
visible surrounding a blue filament that is detached from the skin section.
A
M-18) III - Late
localized
Lesions on dorsal aspect of arms,
thickened callus.
Mild. Positive intracellular Bb staining of basal keratinocytes. Positive Bb staining
of filaments associated with the basal layer. Epidermal layers are well-defined
with no disarrangement and keratinocytes are not vacuolated.
A
M-19) IV - Late
disseminated,
resolving to
III - Late
localized after
treatment
Samples submitted after treatment.
Ulcerative, corporeal, from head to
feet. After treatment resolving
localized on scalp only.
After resolution, irritation of skin,
some sloughing of skin, sensations of
formication.
Mild. Positively Bb stained stratum basale, mostly intracellular staining of
keratinocytes, a few positive, intracellularly stained fibroblasts in dermis. No
hemorrhage. Little to no infiltrate.
A
M-23) IV - Late
disseminated
Corporeal, mostly jawline, legs,
arms, initially vesicular, but later
evolving to ulcerative, and
occasional indurated papules.
Mild. Many small Bb aggregates. Positive Bb staining in and among basal
keratinocytes and keratinocytes in stratum basale. No visible hemorrhage.
A–B
M- 25) IV - Late
disseminated
Corporeal, ulcerative lesions
mostly along jawline, legs, arms,
but later spreading to the back of
torso.
Moderate. Intracellularly Bb stained keratinocytes in the stratum basale. Many Bb
aggregates, including aggregates among filaments are distributed in the stratum
spinosum. Some positive Bb staining of keratinocytes in the stratum spinosum. Some
long positively Bb stained spirochetal forms and or cysts. Strongly Bb stained filaments,
originating at the stratum basale, growing into the dermis. The base of fibers contain
intracellularly Bb stained keratinocytes. No visible hemorrhage.
B–C
M-29) III - Late
localized
Small lesions and calluses on
hands, feet and lower legs. Small
patch of lesions on shoulder
where sunburn occurred.
Mild. Borrelia aggregates scattered in stratum basale, some large. Some aggregates
contain patches of negatively staining bacteria. Cells are disarranged and disturbed in
basal layer, with visible necrosis associated with positive Bb staining. Aggregate colonies
are associated with necrotic pockets. Positively Bb stained fibers originating in stratum
basale. Mass of microfibers surrounding an aggregate. No visible hemorrhage. Large
fiber is associated with Borrelia aggregate.
A–B
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that spontaneous diminution of virulence has occurred.
One hypothesis explaining the decrease in virulence is
that many patients with secondary syphilis may have had
co-infections with other microbial agents, and that co-
infection may have compounded presentation, morbidity,
and mortality of syphilis.38 Irrespective of the presence of
co-involved infections, staging and classification of syphi-
lis remained centered on infection with T. pallidum. As
many MD patients have infections with other tick-borne
pathogens and other human pathogens, it is reasonable to
assume that like syphilis, co-infections may play a role in
augmenting severity of the condition. As spirochetal
Borrelia infection appears to be the key denomination
factor, our staging system for MD will focus on Borrelia.
Immunohistology of MD
Our cohort had serological and/or DNA evidence of
Borrelia spirochetal infection, although prior testing was
not required for selection as study subjects. We observed
a significant spirochetal burden in all the dermatological
specimens from MD lesions that were submitted for study,
regardless of location, lesion characteristic, or length of
illness. The anti-Bb IHC staining was highly specific for
bacteria with morphology consistent with spirochetal
infection, and staining was associated with specific cell
types, namely keratinocytes, fibroblasts and macrophages.
The rabbit anti-Bb polyclonal antibody used in this study
is reported to cross-react with T. pallidum, B. hermsii and
B. parkeri.30 A Borrelia stain with a broad range of spe-
cificity for spirochetal infection that detected both Borrelia
spp. and Treponema spp. was intentionally selected for this
study in order to capture the full spectrum of spirochetes
that could potentially be involved in MD evolution. For
comparison purposes, sections of normal human skin were
stained to determine possible cross-reactivity with com-
monly encountered dermatological microorganisms.12
Normal human skin bacterial flora showed no staining.
Biopsy sections of human skin with fungal infection and
with psoriasis were examined to determine possible cross-
reactivity with other inflammatory dermatological conditions
and to rule out non-specific staining with inflammatory pro-
teins and cells. Staining of psoriasis and fungal infection
biopsy sections was negative, indicating that the staining was
not cross-reactive or non-specific for cells or proteins asso-
ciated with inflammation. Two subjects did have DNA evi-
dence of T. denticola infection in association with Borrelia
infection, but given that every patient had evidence ofBorrelia
infection it appears that this spirochete species is the key
etiologic factor. T. denticola is a common human oral spir-
ochete, and we hypothesize it may have been introduced by
mouth-to-hand-to-lesion transmission or self-inoculation.
Developing a Staging System for MD
As Borrelia is a member of the Spirochaetaceae family like
T. pallidum, the causative agent of syphilis, it was logical
when devising a staging system to make a comparison
between MD lesions and syphilitic lesions. Syphilis is
Table 4 Clinical Classification and Histological Staging of MD
Cohort (n=16 Patients)
Clinical
Classification
Stage
A
Stage
A–B
Stage
B
Stage
B–C
Stage
C
I Early Localized 2 1
II Late Localized 3 2
III Early
Disseminated
IV Late
Disseminated
2 2 2 2
Figure 7 Filaments positively stained for Bb, showing basal cell layer origin. (A) Filaments at 200× magnification showing origin in subcutaneous tissue. (B) Filament at 400×
magnification reactive with anti-Bb immunostain. (C) Filament at 1000× magnification, showing basal origin and cellular composition of keratinocytes that stained
intracellularly positive for Bb at the base of attachment.
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classified into three sequential clinical symptomatic stages of
infection (primary, secondary and tertiary), along with corre-
sponding characteristic skin lesions of each stage.38,39
Primary syphilitic lesions are localized, occurring 2–3 weeks
after initial exposure. If left untreated, the primary lesion heals
in 4–5 weeks, but 4–8 weeks after that the infection becomes
systemic and secondary syphilis develops. Some individuals
have relapsing episodes of secondary syphilis with periods of
latency in between and some may go on to develop tertiary
syphilis, the late manifestation of the disease.39
We do not see systematic progression of MD in quite the
same manner, because MD lesions can develop long after
other systemic symptoms are evident. If an erythema migrans
(EM) rash was present after a tick bite, that stage of Borrelia
infection would be comparable to the primary stage. However,
many LD patients have no history of EM rash,40 and by the
time filamentous lesions develop in most MD patients, the
initial Borrelia infection has passed unnoticed, Lyme-like
symptoms are chronic, and the infectious process is well
established. Presumably, the progression of LD is affected by
the virulence of the Borrelia species, the individual host
response to infection and numerous other secondary etiologi-
cal factors. As stated previously, only a subset of patients with
Borrelia infection developMD lesions,11 but whenMD symp-
toms are present, for most patients the stage of disease pro-
gression is comparable to that of secondary syphilis.
Historical Background of Syphilis Staging
Syphilis is a systemic infection associated with multisystem
symptoms, and cutaneous secondary syphilitic lesions are
localized reactions in tissue induced by metastatic accumula-
tion of treponemes.38 Various classification schemes for syphi-
lis were proposed in the early 20th century. Fournier
differentiated lesions based on location on the skin proper
versus mucous membranes, while Fox proposed that second-
ary syphilitic lesions be grouped into early and late syphilids
Table 5 Proposed Histological Staging System (Middelveen Criteria)
Stage Histological Presentation Defining Features
A – Mild Minor parakeratosis and hyperkeratosis may be present in epidermis. Skin cells are fairly
normal in appearance with little or no cell disarrangement. There is no hemorrhage. There
is little to no inflammatory infiltration.
Intracellular and extracellular Borrelia staining of keratinocytes is present, mainly in the
stratum basale and stratum spinosum. No or few aggregate colonies are present. Isolated
spirochetes and or cysts may be visible. Sectioned filaments may be present, and may be
associated with positive Bb immunostaining.
1. Filaments small and not prominent.
2 No hemorrhage, little or no
infiltration.
3. Infected keratinocytes.
B –
Moderate
Parakeratosis and hyperkeratosis are present in epidermis. Some cell disarrangement may
be present.
Small aggregate colonies and occasional isolated spirochetes may be present.
Borrelia intracellular infection is visible within keratinocytes of the stratum basale and
spinosum and within macrophages.
Small amount of hemorrhage may occur.
Inflammatory infiltrate may be present. Sectioned filaments may be present, and may be
associated with positive Bb immunostaining. Thicker filaments originating in stratum basale
that are positively anti-Bb immunostained at the base may be present.
1. Filaments present.
2. Epidermal parakeratosis and
hyperkeratosis.
3. Minimal hemorrhage with infiltration.
4. Infected keratinocytes and
macrophages.
C –
Severe
Ulceration may cause loss of epidermal cell layer. Inflammatory infiltrates are present,
mostly mononuclear cells (macrophages) indicating chronicity.
There is hemorrhage, and there may be fibrin deposition. There is disarrangement of cells.
Both intracellular and extracellular Borrelia staining is present, mainly occurring
intracellularly within macrophages.
Borrelia immunostaining may reveal Bb in aggregates and maybe a few isolated spirochetes.
Filaments are present and may be associated with patches of Borrelia organisms or larger
Borrelia aggregates (sheath of Borrelia aggregate surrounding fiber in image). Intracellular
Borrelia infection of macrophages is common, and internal replication may evolve into
a Borrelia aggregate, and if the aggregate is sufficiently large it can overtake cell eventually
causing rupture.
Mostly lymphocytic infiltration may be indicative of longstanding infection.
1. Filaments are a prominent feature.
2. Hemorrhage, lymphocytic infiltration
and cell disarrangement.
3. Infected macrophages.
4. Borrelia aggregates.
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(welts), a classification scheme that gained acceptance by the
American Dermatological Association in 1924.38 The second-
ary syphilitic lesions classified as early lesions by this scheme
are described as follows:
1. Macular – the earliest secondary lesions, but fre-
quently overlooked, small (4–8 mm), flat, pale
pink to violaceous spots, that occur on any part
except never on the face;
2. Small papular – small localized skin elevations that
are easily palpated, frequently erupt after macular
rashes, are variable in color, and may occur on any
part of the body, but favor the trunk;
3. Follicular or pseudovesicular – small (pinpoint to
pinhead), round or pointed papules around orifices
of follicles or sweat glands, that tend to group, and
may occur on any part of the body, but are fre-
quently found on genital and anal regions, the
back, upper trunk, arms, thighs and face;
4. Lichenoid – flattened, angulated lesions that resem-
ble lichen planus, appearing on any part of the body,
but most often on the back, upper trunk, and arms;
5. Vesicular – pointed small vesicles that rupture with
difficulty, and can appear on any part of the body;
6. Psoriasiform – resemble psoriasis lesions, but do not
bleed if scale is removed, occurring mostly on the
palms of hands and soles of feet, but may also occur
on the face, elbows, and knees;
7. Corymbiform – nipple-like, usually large lesions
surrounded by smaller lesions, occurring on any
part of the body.
The secondary syphilitic lesions classified as late lesions
by this scheme are described as follows:
1. Large papular – like small papular, but flattened,
may coalesce, occur on any part of the body;
2. Annular – papular lesions with a circinate config-
uration, that spread peripherally forming rings or
gyrate patches, occur on any part of the body, but
favor mucocutaneous areas;
3. Condylomata lata – begin as papules that flatten
becoming macerated, with a thick mucoid exudate
appear in two forms, one flat moist and excoriated in
the center, the other is verrucous, both occur most
frequently on the rectum, scrotum, vulva and groin;
4. Pustular – originates as a vesicle, resembles a papule
with scales, then ruptures becoming flaccid,
containing little if any pus, can form scabs over
concave ulcerations or may appear as a concave
ulceration with no scab formation, occurring on
any part of the body, but favoring the face, nose
flanks, thighs, palms of hands and soles of feet;
5. Rupial – large heavily encrusted pustules that can
appear on any part of the body;
6. Frambesiform – a papular raspberry-like growth,
moist, violaceous, verrucous, that occur on any part
of the body, favoring the face, scalp, mouth, nose, and
less frequently the axilla, anal and genital regions;
7. Pigmentary – vary in size and are not raised, can be
hypopigmented or hyperpigmented, and can appear
on any part of the body.
Regardless of the location and presentation of lesions,
secondary syphilis lesions are local reactions to accumu-
lated treponemes in susceptible tissue.38 Alopecia can
occur in untreated cases of secondary syphilis, arising
from follicular involvement.38 Condylomata lata are large
greyish raised lesions that arise from the breakdown of
secondary lesions in moist areas where tissue trauma has
occurred such as the groin or axilla.38 The treponemal
burden in lesions provides evidence that lesions are pro-
gressive stages of the same infectious process.38
Clinical Diagnosis of MD
Excluding the presence of cutaneous filaments seen in MD
lesions, we have observed comparable characteristic varia-
tion in the manifestation of MD lesions. Like secondary
syphilis, MD results from systemic spirochetal infection.
Our findings indicate that all MD lesions are associated
with a spirochetal burden and, regardless of location and
variation in characteristic appearance, represent the same
infectious process, comparable to syphilis. Based on this
observation, we propose the following criteria and guide-
lines for diagnosing MD:
Diagnostic criteria (Proposed guidelines for diagnos-
ing MD):
1. Primary features (Must include the following):
a. Multicolored filaments embedded within or pro-
truding from the skin
2. Secondary features (May include one or more of the
following):
a. Development of calluses
b. Ulcerative lesions
c. Papules
Dovepress Middelveen et al
Clinical, Cosmetic and Investigational Dermatology 2020:13 submit your manuscript | www.dovepress.com
DovePress
159
 
Cl
in
ica
l, 
Co
sm
et
ic 
an
d 
In
ve
st
ig
at
io
na
l D
er
m
at
ol
og
y 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
7.
25
0.
12
9.
16
6 
on
 1
9-
Ju
n-
20
20
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
d. Burning, itching, stinging, biting
e. Hair loss
f. Atypical hair/nail production
g. Dry appearance with or without flaking skin
h. Edema
i. Hyper- or hypo-pigmentation from scarring
j. Hypertrophic scarring
k. Excoriations
l. Slowly healing lesions
m. Aging skin
We propose the following MD subtypes (How the above
features present, morphological presentation and combina-
tion of above features):
1. Facial
2. Follicular
3. Oropharyngeal/Nasopharyngeal
4. Ophthalmological
5. Central (trunk)
6. Appendicular (extremities)
7. Genitourinary/Vulvovaginal
8. Gastrointestinal/Anorectal
9. Vesicular (some start as liquid-filled blisters, espe-
cially on the hands)
MD lesions are comparable to secondary syphilitic lesions.
However, rather than relying on the systematic progress
from initial infection through sequential clinical stages of
infection, as has been done with syphilis, our staging
focuses on the severity of lesions and corresponding his-
tological findings. Our staging methodology demonstrates
that the level of severity is associated with unique histo-
logical patterns. Mild (Stage A), moderate (Stage B) and
severe (Stage C) MD lesions all demonstrated anti-Bb IHC
staining associated with keratinocytes within the stratum
basale and/or the stratum spinosum. The intracellular anti-
Bb IHC staining of keratinocytes and fibroblasts that we
observed is corroborated by findings in other published
studies.
Borrelia spirochetes can invade fibroblasts and keratino-
cytes, and can replicate intracellularly in these cells.41–43 In
vitro studies demonstrate that intracellular sequestration
enables Borrelia resistance to antibiotic treatment, and may
provide a mechanism for persistent infection.41,42 Likewise,
T. pallidum can localize intracellularly within keratinocytes,
fibroblasts, spermatocytes, interstitial cells and Leydig
cells,44–47 and T. denticola can invade human gingival
epithelial cells.48 Macrophages and keratinocytes are the
cells in which intracellular Borrelia is most frequently
observed. Bb gains entrance into macrophages by
phagocytosis,49 and interestingly keratinocytes can also act
in a phagocytic manner.50,51 Thus, Borrelia may gain
entrance into cells thorough a phagocytic process in patients
with MD.
Histopathology of MD Lesions
Severe MD disease is associated with inflammatory infil-
trate (mainly macrophages), hemorrhage and Borrelia
aggregate colonies. Most importantly, severity of lesions
corresponded with the level of intracellular anti-Bb IHC
staining of macrophages, primarily in the dermis, a finding
that suggests chronicity. A similar pattern of intracellular
T. pallidum infection within macrophages and aggregate
structures was previously recognized in specimens from
secondary and tertiary syphilitic patients.52 Furthermore,
in murine models, Bb rapidly gains entrance into macro-
phages through phagocytosis, normally resulting in degra-
dation. However, Bb may survive phagocytosis and persist
intracellularly, and infection within macrophages may pro-
vide a pathogenic mechanism.49 In MD cases, we do not
know if Bb survives phagocytosis by persisting and repli-
cating within macrophages, but we speculate that given the
frequency of this finding, it occurs in severe MD cases. As
a result, survival within macrophages may contribute to
spirochete persistence and recalcitrance, like survival
within keratinocytes and fibroblasts. Thus, significant
Borrelia accumulation occurs within keratinocytes, fibro-
blasts and macrophages and, hypothetically, Bb intracellu-
lar survival and replication could result in cell rupture and
formation of aggregate colonies, as shown recently.15
MD filaments originated in subcutaneous locations, empha-
sizing that these fibers could not have been externally implanted
(Figure 7A). MD filaments originating in the basal cell layer
reacted intensely with anti-Bb IHC staining (Figure 7B and C).
The base of attachment and lower shaft of MD filaments
demonstrated a composition of intracellularly anti-Bb IHC-
stained keratinocytes that was continuous with the basal cell
layer (Figure 7C). This specific staining pattern shows a direct
association betweenMD filament formation andBorrelia infec-
tion: the fact that the organism presumed to be responsible for
MD dermopathy is visible in areas demonstrating the key
diagnostic criterion for MD is suggestive of a causal relation-
ship. The presence of Bbsl, and possibly co-involvement of
other pathogens, in MD skin may result in altered gene regula-
tion and expression of keratin, collagen and melanin, that
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induce the production of aberrant filaments.8,9 In support of this
hypothesis, co-culture of human fibroblasts with Bbsl enhances
collagen mRNA expression in vitro and stimulates the growth
factors responsible for increased collagen production.53
Diagnostic Approach to Syphilis
Secondary syphilis and MD associated with Borrelia
infection are both systemic diseases associated with
a variety of musculoskeletal, neurological and cardiac
symptoms.4,11,39,49 Correctly diagnosing these spirochetal
infections is therefore of paramount importance, and
recognizing the associated dermopathy can aid in diagno-
sis. In diagnosing MD, we can take a lesson from the
example of syphilis. The diagnosis of syphilis involves
a range of different acceptable direct and indirect testing
methods. Serological tests are the primary means of diag-
nosis and include specific treponemal tests and non-
specific non-treponemal tests.39 Most diagnoses are based
on clinical appearance with supporting serological evi-
dence: reactivity to cardiolipin (VDRL and RPR tests),
and/or reactivity to treponemal outer membrane proteins
(MHA-TP).49 More recently, automated EIA tests and
simple dipstick tests have become available.39
Serological detection is sufficiently sensitive and specific
for most cases of syphilis, but serology may lack sensitivity
and/or specificity in the early phases and for certain mani-
festations of the disease; therefore, other methods have been
used for detection.54 Although not frequently performed,
direct detection of spirochetes in primary and secondary
syphilitic lesions by darkfield microscopy is an acceptable
means of diagnosis. In addition, diagnosis may be based on
histological examination of biopsy material using a silver
staining method or IHC staining, and a new variation of IHC
staining, focus floating microscopy (FFM), is now
available.39,49,54 DNA amplification of T. pallidum gene
targets by PCR technology is also an accepted diagnostic
method and reportedly has a specificity and sensitivity com-
parable to serological methods.39
Diagnostic Approach to LD and MD
In contrast to the broad range of acceptable testing methods for
syphilis, testing for Borrelia infection in North America, as
recommended by the Infectious Diseases Society of America
(IDSA) and the US Centers for Disease Control and Prevention
(CDC), is focused on detection of LD, and relies on a single,
defective, insensitive serological test protocol.31,32,55–57 The
recommended testing is a two-tiered test protocol consisting
of a screening assay for serum antibodies – either an Enzyme
Immunoassay (EIA) or an Immunofluorescence Assay (IFA). If
positive, a confirmatory Western Blot is performed. The IgM
Western Blot is performed only if the patient has been sympto-
matic for less than or equal to 30 days; and the IgG Western
Blot is performed if the patient has had symptoms for greater
than 30 days.58 Patients with late or longstanding LD frequently
demonstrate prolonged IgM seroreactivity that should be
addressed by testing. Other deficiencies in LD testing arise
from the fact that CDC endorsed commercial LD test kits are
based on antigens from a single Bbss strain, B-31, and are not
capable of detecting antigenic reactivity to the many Bbsl and
RFB species and strains that lack cross-reactivity.9,13,32
There are nine species of Bbsl that are said to have human
pathogenic potential: B. afzelii, B. bavariensis, B. bissettii,
B. burgdorferi sensu stricto, B. garinii, B. kurtenbachii,
B. lusitaniae, B. spielmanii, and B. valaisiana.59 Our under-
standing of Bbsl infection is in its infancy, however, and some
species classified as non-pathogenic may yet be shown to cause
human disease.60 Our knowledge of RFB is even more limited
in scope than our knowledge of Bbsl. In the USA, there is no
case definition for relapsing fever (RF) and it is not nationally
reportable.61 Most human cases are reported in the Western
states and include: B. miyamotoi, B. hermsii, B. lonestari,
B. parkeri, B. turicatae, and B. mazzottii.62–68 Bb and RFB
are antigenically distinct with unique Western blot band pat-
terns; therefore tests based on Bb antigens do not adequately
detect RFB.13,32 Ideally, serological testing for Borrelia spiro-
chetes in MD patients should encompass the full spectrum of
spirochetes associated with the dermopathy.
Although it is insensitive, serological testing is helpful
for diagnosing LD because most patients with LD do not
have spirochetal infection that is detectable by direct
detection methods. However, patients with MD have
a visible manifestation of infection that is easily identifi-
able by the MD case definition, and spirochetal infection is
detectable in dermatological tissue by direct detection
methods, providing that the correct methodologies are
used.8,9,12,13,15,17,18 Methodologies that should be accepted
as corroborative diagnostic evidence of spirochetal infec-
tion in MD patients should include those that can directly
detect Borrelia spirochetes in skin specimens from tissue
showing dermopathy. This can be accomplished by histo-
logical sectioning and staining with silver stains, IHC,
FFM and or FISH; and by DNA detection using PCR
technology.8,9,12,13,15,17,18 Culturing from skin specimens
and from other tissues and bodily fluids can also be an
effective means of detecting spirochetal infection in MD
patients.8,9,12 It is imperative that reliance on a single
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faulty serological method for diagnosing suspected LD
should be upgraded and that other more sensitive techni-
ques should be included in the repertoire of accepted
diagnostic tools for MD.
Conclusions
This is the first proposed staging and classification system
for MD that further illuminates this contested illness. The
evidence presented here supports MD evolution as being
directly associated with spirochetal infection, bearing
similar historical and pathological parallels to syphilis.
Establishing an MD staging system validates the disease
as a true somatic illness and should serve as a template for
diagnosis. Further research is needed to understand the
mechanisms behind this complex disease process.
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